Brown Brothers Harriman & Co’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,524	Closed	-$45K	–	1521
2022 Q2	$45K	Sell	1,524 -500	-25%	-$13.1K	﹤0.01%	725
2022 Q1	$65K	Sell	2,024 -7,000	-78%	-$241K	﹤0.01%	717
2021 Q4	$402	Buy	9,024 +6,524	+261%	+$309K	﹤0.01%	367
2021 Q3	$126	Sell	2,500 -3,553	-59%	-$200K	﹤0.01%	528
2021 Q2	$475	Buy	6,053 +5,000	+475%	+$309K	﹤0.01%	323
2021 Q1	$60	Sell	1,053 -17	-2%	-$1.14K	﹤0.01%	615
2020 Q4	$90K	Buy	+1,070	New	+$64.7K	﹤0.01%	574
2020 Q1	–	Sell	-2,316	Closed	-$40K	–	1144
2019 Q4	$40K	Hold	2,316	–	–	﹤0.01%	705
2019 Q3	$35K	Hold	2,316	–	–	﹤0.01%	704
2019 Q2	$48K	Hold	2,316	–	–	﹤0.01%	591
2019 Q1	$54K	Hold	2,316	–	–	﹤0.01%	563
2018 Q4	$48K	Buy	+2,316	New	+$42K	﹤0.01%	517